SV

Sainath Vramarathnam Iyer

Active Director Director DIN 08590081
DIN 08590081 First appointment Oct 2019 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2019
Shareholding value •••• Premium profile

About Sainath Vramarathnam Iyer

Data last updated:

Sainath Vramarathnam Iyer is a Director at Cibeles Pharmaceuticals Private Limited (since 2019). The company operates in Pharma. Cibeles Pharmaceuticals Private Limited reported revenue of ₹27.15 Cr (FY 2025).

DIN 08590081
Primary Designation Director
Industry Pharma
First Appointment 22 Oct 2019
Oldest Company Age 7 yrs
Largest company Cibeles Pharmaceuticals Private Limited · ₹27.15 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director22 Oct 20192019₹27.15 Cr (FY 2025)Active

Board colleagues of Sainath Vramarathnam Iyer

Directorship timeline

Open interactive timeline →
Cibeles Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sainath Vramarathnam Iyer

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sainath Vramarathnam Iyer

Sainath Vramarathnam Iyer currently holds 1 directorship: Cibeles Pharmaceuticals Private Limited (Director, since 22 Oct 2019, revenue ₹27.15 Cr (FY 2025)).

Sainath Vramarathnam Iyer was first appointed on 22 Oct 2019 as Director at Cibeles Pharmaceuticals Private Limited.

The current boards of Sainath Vramarathnam Iyer's companies include Dheer Dharmesh Shah (Cibeles Pharmaceuticals Private Limited), Trushit Pramodray Mehta (Cibeles Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available